The FDA has approved pirtobrutinib (Jaypirca) treatment for adults with relapsed/refractory chronic lymphocytic leukemia or ...

A patient acuity model drove efficient and safe staffing through data from a natural language processing model informed by ...

With evolving standards for handling hazardous drugs, nurses must comply with safety and handling guidelines.

The FDA approved the combination of durvalumab (Imfinzi) plus FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and ...

Coiro, an advanced practice nurse practitioner at the John Theurer Cancer Center at Hackensack University Medical Center Stem ...

The most powerful thing we offer is not a medication or a skill: it’s presence. Presence steadies a hand during uncertainty ...

Standard treatments recommended by NCCN Guidelines for this setting include fruquintinib (Fruzaqla), regorafenib (Stivarga), ...

Kristin Daly, MSN, ANP-BC, AOCNP, shares advice for preparing patients for possible adverse effects outside of clinic hours.

Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN, is editor in chief of Oncology Nursing News®. She is a long tenured oncology clinical nurse specialist who has practiced in both Comprehensive Cancer ...

The multi-day nature of standard chemotherapy regimens used in extensive-stage small cell lung cancer (ES-SCLC) creates ...

Luspatercept-aamt (Reblozyl) is among the National Comprehensive Cancer Network (NCCN) guideline recommendations for low-risk ...

The FDA has converted its 2024 accelerated approval of tarlatamab-dlle (Imdelltra) for the treatment of adults with extensive ...